Biocon Limited (BIOCON)
NSEINR 341.91.65%
Price Chart
Key Statistics
Market Cap
INR 403.71B
P/E Ratio
50.20
Revenue (TTM)
INR 147.62B
Volume
1.68M
52W High
INR 404.70
52W Low
INR 247.21
Dividend Yield
0.15%
Beta
0.43
Technicals
50-Day MA
355.404
200-Day MA
351.825
52 Week High
404.7
52 Week Low
247.2076
About BIOCON
Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates throug.
Employees
16315
Headquarters
Bengaluru, India
CEO
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc.
Latest News
FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek - The Center for Biosimilars
2024-12-02 • Google News
Latham Advises on Biocon Biologics’ US$800 Million Senior Notes Offering - Latham & Watkins LLP
2024-10-10 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg